Sageworth Trust’s Idexx Laboratories IDXX Stock Holding History

Sageworth Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23	Closed	-$15K	–	554
2021 Q4	$15K	Sell	23 -77	-77%	-$48.3K	﹤0.01%	217
2021 Q3	$62K	Hold	100	–	–	0.01%	162
2021 Q2	$63K	Buy	+100	New	+$55.2K	0.01%	203
2017 Q2	–	Sell	-200	Closed	-$31K	–	118
2017 Q1	$31K	Buy	+200	New	+$27.6K	0.01%	51

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Sageworth Trust's IDXX Position: Q1 2022 in Review

Sageworth Trust sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 23 shares — an estimated $15K sold.

Sageworth Trust first reported a position in IDXX in Q1 2017 and held it in 4 quarters. The position peaked at $63K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Sageworth Trust reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Sageworth Trust sold 23 Idexx Laboratories shares in Q1 2022, an estimated $15K.
Sageworth Trust first reported a position in Idexx Laboratories in Q1 2017 and held it in 4 quarters.
Sageworth Trust's Idexx Laboratories position peaked at $63K in Q2 2021.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.